These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1669033)

  • 1. [Treatment of depression by a combination of clomipramine and triiodothyronine].
    Souche A; Baumann P; Koeb L; Thermoz P; Azorin JM; Dufour H
    Encephale; 1991; 17(1):37-42. PubMed ID: 1669033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial increase of plasma serotonin: a biological predictor for the antidepressant response to clomipramine?
    Spreux-Varoquaux O; Gailledreau J; Vanier B; Bothua D; Plas J; Chevalier JF; Advenier C; Pays M; Brion S
    Biol Psychiatry; 1996 Sep; 40(6):465-73. PubMed ID: 8879466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early response patterns associated with successful clomipramine treatment.
    Pollock BG; Perel JM; Kupfer DJ; Bowler KA; Miewald JM
    J Clin Psychopharmacol; 1993 Dec; 13(6):442-7. PubMed ID: 8120158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine].
    Champiat JC; Aymard N; des Lauriers A
    Encephale; 1983; 9(1):23-36. PubMed ID: 6872932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levels of clomipramine and declomipramine in patients with depression: a study of its correlation with therapeutic efficacy].
    Wargny E; Lamiable D; Havet JM; Denis J; Millart H; Choisy H; Pascalis G
    Ann Med Psychol (Paris); 1986 Apr; 144(4):396-406. PubMed ID: 3813333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothyroidism and hyperthyroidism in major depression revisited.
    Fava M; Labbate LA; Abraham ME; Rosenbaum JF
    J Clin Psychiatry; 1995 May; 56(5):186-92. PubMed ID: 7737957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)].
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Encephale; 1981; 7(5):601-8. PubMed ID: 7327152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid functioning during treatment for depression.
    Kusalic M; Engelsmann F; Bradwejn J
    J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders.
    Manna V; Martucci N; Agnoli A
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():81-8. PubMed ID: 2644342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial with oral versus intravenous clomipramine in primary depression.
    Faravelli C; Broadhurst AD; Ambonetti A; Ballerini A; De Biase L; La Malfa G; Das M
    Biol Psychiatry; 1983 Jun; 18(6):695-706. PubMed ID: 6871303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled study of treatment of residual depression by clomipramine versus placebo].
    Rouillon F; Markabi S; Febvre N; Phillips R; Vaillant J
    Encephale; 1994; 20(2):139-45. PubMed ID: 8050380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
    Szegedi A; Wetzel H; Leal M; Härtter S; Hiemke C
    J Clin Psychiatry; 1996 Jun; 57(6):257-64. PubMed ID: 8666564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
    Yamada K; Yagi G; Kanba S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative neurotransmitter reuptake and anticholinergic potencies of the 8-hydroxy metabolites of clomipramine.
    Núñez R; Perel JM
    Psychopharmacol Bull; 1995; 31(2):217-21. PubMed ID: 7491371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.
    Smith WT; Glaudin V; Panagides J; Gilvary E
    Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.